Auvelity Tablet, Multilayer, Extended Release
Product Images NDC 81968-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Auvelity (NDC 81968-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Axsome Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dextromethorphan Hydrobromide)

FDA Label Image

Structural Formula (Bupropion Hydrochloride)

FDA Label Image

Figure 1 (Auvelity 03)

FDA Label Image

Figure 2 (Auvelity 04)

Figure 2 (Auvelity 04)
This appears to be the output of statistical analysis, including the mean effect and 90% confidence interval for several drugs and their corresponding inhibitors or inducers. Specifically, the analysis mentions the effect of Paroxetine and Clopidogrel, and the inhibitors or inducers of CYP2D6 and CYP286. The text also includes some numerical values for various drugs, such as Carbamazepine, and their corresponding drug concentrations over time. Additionally, there is a section on changes relative to a reference.*
FDA Label Image

Figure 3 (Auvelity 05)

Figure 3 (Auvelity 05)
The text describes a study with two groups - Placebo (N=162) and AUVELITY (N=156) that measured changes in MADRS Total Score over time, using weeks 0 through 5. The table shows data for the LS Mean (SE) change from baseline for each group over the six week period.*
FDA Label Image

30-count Bottle Label (Auvelity 06)

30-count Bottle Label (Auvelity 06)
This is a medication called Auvelity, an extended-release tablet which contains 45 mg of dextromethorphan hydrobromide and 105 mg of bupropion hydrochloride. It is used as per the prescribing information and should be stored at temperatures between 20°C to 25°C (68°F to 77°F). This medication is manufactured by Axsome Therapeutics and is available in a bottle containing 30 tablets. It is to be swallowed whole without crushing, dividing, or chewing, and it is not to be used if the seal is broken. The accompanying medication guide should be carefully read before use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.